Effect of testosterone on growth of P388 leukemia cell line in vivo and in vitro. Distribution of peripheral blood T lymphocytes and cell cycle progression

Neoplasma

Volumn 52, Issue 3, 2005, Pages 260-266

  Aboudkhil, S ^a,b,c   Henry, L ^c   Zaid, A ^b   Bureau, J P ^c  

^a HASSAN II UNIVERSITY OF CASABLANCA   (Morocco)

^b MOULAY ISMAIL UNIVERSITY   (Morocco)

^c UNIV MONTPELLIER   (France)

Author keywords

Cell cycle; P388 leukemia cell line; Peripheral blood lymphocyte; Subsets T cells; Testosterone; Tumor tissue

Indexed keywords

TESTOSTERONE; TESTOSTERONE CIPIONATE;

ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; LEUKEMIA CELL LINE; MALE; MOUSE; NONHUMAN; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 20144372760     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. AABO K, VINDELOV LL, CHRISTENSEN IB, SPANG-THOMESEN M. Interactions between three subpopulations of ehrlish ascites tumor and a P388 murine leukemia in mixed solid tumors in immune competent mice. APMIS 1989; 97: 212-220.
2. ABOUDKHIL S, BUREAU JP, GARRELLY L, VAGO P. Effects of castration, depo-testosterone and cyproterone acetate on lymphocyte T subsets in mouse thymus and spleen. Scand J Immunol 1991; 34: 647-653.
3. AHMED A, DAUPHINEE M, TALAL N. Effects of short term administration of sex hormones on normal and autoimmune mice. J Immunol 1985; 134: 204-210.
4. BOON T, CEROTTINI JC, VAN DEN EYND B, VAN DER BRUGEN P, VAN PEL A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994; 12: 337-365.
5. CAMILLO P, DANOVA M, ORENGO AM, FERRINI S, MORONI M et al. Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro. J Cell Physiol 2000; 185: 126-134.
6. CUTOLO M, SULLI A, CARAVIOTTO C, FELLI L, PIZZORNI C et al. Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. Ann NY Acad Sci 2002; 966: 204-210.
7. DANEL L, VINCENT F, ROUSSET B, KLEIN B, BATAILLE R et al. Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas. J Steroid Biochem 1985; 21: 421.
8. EVERAUS H. Hormones and immune responsiveness in chronic lymphocytic leukemia. Leuk Lymphoma 1992; 8: 483-489.
9. EVERAUS H, LEHTMAA J, LUIK E, KODAR H. Immune and hormonal changes in early-stage chronic lymphocytic leukemia patients. Annals Hematol 1992; 65: 219-223.
10. FUKUOKA K, YAMAGISHI T, ICHIHARA T, NAKAIKE S, IGUCHI K et al. Mechanism of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G(1) phase of the cell cycle. International J Cancer 2000; 88: 810-819.
11. GEISSLER M, WANDS G, GESIEN A, DELAMONTE S, BELLET D et al. Genetic immunization with the free human chorionic gonadotropin beta-subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice. Lab Invest 1997; 76: 859-871.
12. GREGORY CW, JOHSO RT, PRESELL SC, MOHLER JL, FRECH FS. Adrogen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft. J Androl 2001; 22(4): 537-548.
13. GREIMERS R, RONGYAM, DEFRESNE MP, BONIVER J, HOOGHE R. Phenotype of thymic lymphomas in the mouse. Leukemia Res 1986; 10(7): 777-782.
14. HOLLARD D, SOTTO JJ, BERTHIER R, LEGER J, MICHALLET M. High rate of long-term survivals in AML treated by chemotherapy and androgentherapy: pilot study. Cancer 1980; 45: 1540.
15. HOOGHE R, BONIVER J. Thymic lymphomas in the mouse. Immunology Today 1985; 6: 240-242.
16. KIMIHARU U, TOSHIAKI U, MAKI O, SATOKO N, YOSHIFUSA T et al. Serum dehydroepiandrosterone and DHEA-sulfate in patients with adult T-cell leukemia and human T-lymphotropic virus type I carriers. Am J Hematol 1996; 53: 165-168.
17. KOEFFER HP. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 1983; 62: 709-721.
18. LIVA SM, VOSKUHL RR. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 2001; 167: 2060-2067.
19. MOSSUZ P, COUSIN F, CASTINEL A, CHAUVET M, SOTTO MF et al. Effects of two sex steroids (17 alpha-estradiol and testosterone) on proliferation and clonal growth of the human monoblastic leukemia cell line, U937. Leuk Res 1998; 22: 1063-1072.
20. OSHIMA K, HAROKA S, SUZUMIYA J, SUGIHARA M, KANDA M et al. Absence of cytotoxic molecules in CD8- and/or CD56-positive adult T-cell leukemia/lymphoma. Virchows Arch 1999; 435: 101-104.
21. OWA T, YOSHINO H, OKAUCHI T, YOSHIMATSU K, OZAWA Y et al. Discovery of novel antitumor sulfamides targeting G1 phase of the cell cycle. J Med Chem 1999; 42: 3789-3799.
22. QUN H, DEZHAO J. A novel aminosteroid is active for proliferation inhibition and differntiation induction of human acute myeloid leukemia HL-60 cells. Leukemia Res 1999; 23: 369-372.
23. RAVECHE ES, STEINBERG AD, DEFRANCO AL, TJIO, JH. Cell cycle analysis of lymphocyte activation in normal and autoimmune strains of mice. J Immunol 1982; 129: 1219-1226.
24. SEGAL BM, GLASS DD, SHEVACH EM. Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejection. J Immunol 2002; 168: 1-4.
25. SERRERO G, LEPAK NM, HAYASHI J, EISENGER DP. Effect of testosterone on the growth properties and on epidermal growth factor receptor expression in the teratoma-derived tumorigenic cell line 1246-3A. Cancer Res 1992; 52: 4242-4247.
26. VINDELOV L, CHRISTENSEN I. Some methods and applications of flow cytometric DNA analysis in clinical and experimental oncology. Eur J Haematol 1989; 42; 69-76.
27. VINDELOV L, CHRISTENSEN I, JENSEN G, NISSEN N. Limits of detection of nuclear DNA abnormalities by a set of methods for sample storage, staining and internal standardization. Cytometry 1983; 3: 328-331.
28. VISELLI SM, STANZIALE S, SHILTS K, KOVACS WJ, OLSEN N. Castration alters peripheral immune function in normal male mice. Immunology 1995; 84: 337-342.